Nantahala Capital Management, LLC Unicycive Therapeutics, Inc. Put Options Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding UNCY
# of Institutions
27Shares Held
17.5MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.47MShares$1.6 Million0.26% of portfolio
-
Logos Global Management LP San Francisco, CA3.47MShares$1.6 Million0.16% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.63MShares$1.21 Million0.02% of portfolio
-
Bvf Inc San Francisco, CA2.2MShares$1.01 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.14MShares$523,5810.0% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $6.92M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...